| 4.72 -0.03 (-0.63%) | 07-08 11:41 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.94 | 1-year : | 6.36 |
| Resists | First : | 5.09 | Second : | 5.45 |
| Pivot price | 4.86 |
|||
| Supports | First : | 4.51 | Second : | 3.75 |
| MAs | MA(5) : | 4.88 |
MA(20) : | 4.96 |
| MA(100) : | 5.04 |
MA(250) : | 5.33 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2  |
| %K %D | K(14,3) : | 32.9 |
D(3) : | 41.8 |
| RSI | RSI(14): 40.6 |
|||
| 52-week | High : | 6.36 | Low : | 4.28 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ TPVG ] has closed above bottom band by 33.8%. Bollinger Bands are 2.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.96 - 4.99 | 4.99 - 5.01 |
| Low: | 4.68 - 4.72 | 4.72 - 4.75 |
| Close: | 4.7 - 4.76 | 4.76 - 4.8 |
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
Sun, 28 Jun 2026
TPVG Forecast — Price Target — Prediction for 2027 - TradingView
Fri, 26 Jun 2026
TriplePoint Venture Growth BDC Corp. Actuals & Estimates (NYSE:TPVG) - TradingView
Wed, 17 Jun 2026
Triplepoint Venture Growth BDC Corp - TradingKey
Thu, 28 May 2026
TriplePoint Venture Growth: Another Dividend Cut Likely (NYSE:TPVG) - Seeking Alpha
Thu, 28 May 2026
TPVG - TriplePoint Venture Growth BDC Corp Stock Price and Quote - Finviz
Wed, 06 May 2026
TriplePoint Venture Growth (NYSE: TPVG) Q1 2026 yield, dividend and buyback - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 41 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 9.6 (%) |
| Shares Short | 2,390 (K) |
| Shares Short P.Month | 2,280 (K) |
| EPS | 1.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.64 |
| Profit Margin | 47 % |
| Operating Margin | 78 % |
| Return on Assets (ttm) | 5.5 % |
| Return on Equity (ttm) | 12.2 % |
| Qtrly Rev. Growth | 1.3 % |
| Gross Profit (p.s.) | 2.23 |
| Sales Per Share | 2.23 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -52 % |
| Operating Cash Flow | -59 (M) |
| Levered Free Cash Flow | 34 (M) |
| PE Ratio | 4.52 |
| PEG Ratio | 2.7 |
| Price to Book value | 0.54 |
| Price to Sales | 2.12 |
| Price to Cash Flow | -3.3 |
| Dividend | 0.23 |
| Forward Dividend | 0 |
| Dividend Yield | 4.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|